Singapore markets open in 2 hours 10 minutes

Valneva SE (VALN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
33.71+2.06 (+6.51%)
At close: 04:00PM EST
33.50 -0.21 (-0.62%)
After hours: 04:11PM EST
Full screen
Trade prices are not sourced from all markets
Previous close31.65
Open32.45
Bid33.03 x 1100
Ask41.00 x 900
Day's range31.92 - 36.62
52-week range24.16 - 67.84
Volume395,568
Avg. volume95,798
Market cap1.806B
Beta (5Y monthly)0.65
PE ratio (TTM)N/A
EPS (TTM)-3.07
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est65.43
  • Zacks

    Valneva (VALN) Up as COVID-19 Jab Neutralizes Omicron Variant

    Three doses of Valneva's (VALN) inactivated COVID-19 vaccine candidate, VLA2001, neutralizes the Omicron variant of SARS-CoV-2, per data from preliminary lab studies. Shares rally.

  • Reuters

    Shares in COVID-19 vaccine developer Valneva extend fall

    Shares in biotech company Valneva fell again on Wednesday, declining for the seventh day in a row due to a growing belief amongst investors that the COVID-19 Omicron variant might lessen the need for mass vaccination. At 0945 GMT, Valneva shares were down 3% at 17.10 euros, meaning the stock has now lost close to 40% since its Dec. 27 close of 26.38 euros. It did gain more than 200% a year in 2021 and 2020 as Valneva's COVID-19 vaccine candidate came increasingly closer to approval.

  • Motley Fool

    Is This New Data on Valneva's Less-Effective Booster Concerning?

    Some recent dismal results for Valneva's vaccine looked bad. But there could be more to the story.